Androgen deprivation and cognition in prostate cancer

British Journal of Cancer

Volumn 89, Issue 6, 2003, Pages 971-976

  Salminen, E ^a   Portin, R ^a   Korpela, J ^a   Backman, H ^a   Parvinen, L M ^a   Helenius, H ^b   Nurmi, M ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Androgen deprivation; Cognition; Prostate cancer; Quality of life

Indexed keywords

ANDROGEN;

ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; ATTENTION; BECK DEPRESSION INVENTORY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER THERAPY; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; COMPUTER PROGRAM; CONTROLLED STUDY; DEPRESSION; HUMAN; LONGITUDINAL STUDY; MALE; MEMORY; NEUROPSYCHOLOGICAL TEST; PATIENT COUNSELING; PHYSICAL DISEASE; PRIORITY JOURNAL; PROSTATE CARCINOMA; QUALITY OF LIFE; SOCIAL PSYCHOLOGY; SUPPORT GROUP; VERBAL BEHAVIOR; VISUOMOTOR COORDINATION;

AGED; ANDROGEN ANTAGONISTS; CASE-CONTROL STUDIES; COGNITION; COMBINED MODALITY THERAPY; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 0141887365     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601235     Document Type: Article

References (34)

1. Barrett-Connor E, Goodman-Gruyen D, Patay B (1999) Endogenous sexual hormones and cognitive function in older men. J Endocrinol Metab 84: 3681-3685
2. Beck AT, Rial WY, Rickels K (1974) Short form of depression inventory: cross-validation. Psychol Rep 34: 1184-1186
3. Benton AL (1993) Revised Visual Retention Test. New York: Psychological Corporation
4. Bolla M, Gonzalez D, Worde P, Dubois J, Minmanoff RO, Storme K, Bernitz J, Kuhen A, Sternberg C, Gil T, Collette L, Plerart M (1997) Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med 337: 295-300
5. Cherrier M, Anwalt B, Herlst K, Amory J, Craft S, Matsumoto AM, Brvemmer WJ (2001) Testosterone supplementation improves spatial and verbal memory in healthy older men. Neurology 10: 80-88
6. Cull A, May C, Love S, Mackie M, Smets E, Stewart M (1966) What do patients mean when they complain of concentration and memory problems? Br J Cancer 74: 1674-1679
7. Demers R, Tiwari A, Wei J, Wein Z, Serenson R, Montie J (2001) Trends in utilization of androgen-deprivation therapy for patients with prostate carcinoma suggest an effect on mortality. Cancer 92: 2309-2317
8. Fayers P, Aaronson N, Bjordal K, Sullivan M (1997) EORTC QLQ-C30 Scoring Manual. Brussels: EORTC Publications
9. Folstein MF, Folstein SE, McHugh PR (1975) 'Mini Mental State': a practical method for grading the cognitive state of patients for clinician. J Psychiatr Res 12: 189-198
10. Fransson P, Dambü J, Tomic R, Modig H, Nyberg G, Widmark A (2001) Quality of life and symptoms in a randomized trial of radiotherapy versus deferred treatment of localized prostate carcinoma. Cancer 92: 3111-3119
11. Gee WF (1995) Practise trends in the diagnosis and management of prostate cancer in USA. J Urol 154: 207-208
12. Gleave M, Goldenberg S, Chin J, Warner J, Saad F, Klotz L, Jewett M, Kassalian V, Chetner M, Dupont C, Van Reusselaer S, the Canadian UroOncology Group (2001) Randomized comparative study of 3 versus 8-month neoadjuvant hormonal therapy before radical prostatectomy: biochemical and pathological effects. J Urol 166: 500-507
13. Green H, Palanham K, Headley B, Gardiner R (2002a) Altered cognitive functioning in men treated for prostate cancer with luteinizing hormone-releasing hormone analogues and cyprotenone acetate: a randomized controlled trial. BJU Int 90: 427-432
14. Green H, Palanham K, Headley B, Gardiner R (2002b) Coping and health-related quality of life in men with prostate cancer randomly assigned to hormonal medicationor close monitoring. Psycho-oncology 11: 401-414
15. Kujala P, Portin R, Revonsuo A, Ruukainen J (1994) Automatic and controlled information processing in multiple sclerosis. Brain 117: 1115-1126
16. Kujala P, Portin R, Ruutiainen J (1997) The progress of cognitive decline in multiple sclerosis - a controlled 3-year follow-up. Brain 120: 289-297
17. Lezak MD (1995) Neuropsychological assessment, 3rd edn. New York: Oxford University Press
18. Lilja A, Portin R, Hamalainen P, Salminen E (2001) Short-term effects of radiotherapy on attention and memory performances in patients with brain tumours. Cancer 91: 2361-2368
19. Littell R, Milliken GA, Stroup W, Wolfinger RD (1996) SAS® System for Mixed Models. Cary, NC: SAS Institute Inc.
20. Lubeck D, Grossfeld G, Carroll P (2001) The effect of androgen deprivation therapy on health-related quality of life in men with prostate cancer. Urology 58(Suppl 2a): 94-100
21. Ly L, Juminez M, Huang T, Celermayer D, Conway A, Handesman D (2001) A double-blind, placebo controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency. J Clin Endocrinol Metab 86: 4078-4088
22. Miller AB, Hoogstraten B, Staguet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47: 201-214
23. Newling D (2000) Tailoring of hormonal therapy in prostate cancer. Prostate Cancer PD 3: 21-27
24. O'Connor D, Archer J, Hair W, Wu F (2001) Activational effects of testosterone on cognitive function in men. Neuropsychology 39: 1385-1394
25. Post P, Stockton D, Davies D, Coebergh J (1999) Striking increase in incidence of prostate cancer in men aged <60 years without improvement of prognosis. Br J Cancer 79: 13-17
26. Potosky A, Knopf K, Clegg L, Albertsen P, Stanford J, Hamilton A, Gilliland F, Elev J, Stephenson R, Hoffman R (2001) Quality of life outcomes after primary androgen deprivation therapy: Results from the prostate cancer outcomes study. J Clin Oncol 19: 3750-3757
27. Potosky A, Reeve B, Clegg L, Hoffman R, Stephenson R, Albertsen P, Gilliland F, Stanford J (2002) Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy. J Natl Cancer Inst 94: 430-437
28. Revonsuo P, Portin R (1995) CogniSpeed© The Computer Based Measurement of Cognitive Processing. University of Turku, Turku, Finland: Aboa Tech Ltd
29. Salminen E, Lempainen L, Nurani M, Baerman H, Parunen LM, Portin R (2002) Investigation on androgen deprivation with radical radiotherapy of prostate cancer. In Progress in Radio-Oncology, vol. 11, Kogelnik H, Lukas P, Sedlmayer F (eds) pp 75-81. Bologna, Italy: Monduzzi Editore
30. Van Dam F, Schlagen S, Muller MG, Boogard W, Wall E, Droogleever-Fortujn M, Rodenhuis S (1998) Impairment of cognitive function in women receiving adjuvant treatment for high risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst 90: 210-218
31. Wechsler D (1955) Manual for the Wechsler Adult Intelligence Scale. New York: Psychological Corporation
32. Wechsler D (1987) WMS-R, Wechsler Memory Scale-Revised. Manual. New York; Psychological Corporation, Harcourt Brace Jovanovich, Inc.
33. Wolf O, Hellhammer D, Kudillea B, Schurmeyer T, Kirschbaum C (2000) Testosterone and cognition in elderly men: a single testosterone injection blocks the practice effect in verbal fluency, but has no effect on spatial or verbal memory. Biol Psychiatry 47: 650-654
34. Yang FE, Song PY, Wayne J, Vaida F, Vijayakumar S (1998) A new look at an old option in the treatment of early-stage prostate cancer: hormone therapy as an alternative to watchful waiting. Med Hypotheses 51: 243-251